Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | 63,368 | reported | 01 Jul 2025 | tx 485+1,547,103−1,442,995 |
| Dare Bioscience, Inc. | 13,104 | reported | 03 Jan 2017 | tx 4+55,104 |
| RHYTHM PHARMACEUTICALS, INC. | 7,037 | reported | 24 Jun 2025 | tx 14+137,249−7,000 |
| ALNYLAM PHARMACEUTICALS, INC. | 1,441 | reported | 20 May 2026 | tx 3+5,391 |
| Praxis Precision Medicines, Inc. | 1,166 | reported | 06 Feb 2026 | tx 3+1,390 |
| IMMUNOGEN INC | 0 | reported | 12 Feb 2024 | tx 29+284,368−295,035 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 671 | 0.00 USD | |
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 1,441 | 0.00 USD | deriv |
| 06 Feb 2026 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 688 | 0.00 USD | |
| 06 Feb 2026 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 478 | 0.00 USD | |
| 06 Feb 2026 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 224 | 0.00 USD | deriv |
| 05 Jan 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 3,279 | 0.00 USD | deriv |
| 01 Jul 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 37,243 | 450.23 USD | |
| 24 Jun 2025 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 7,037 | 0.00 USD | deriv |
| 24 Jun 2025 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 4,712 | 0.00 USD | deriv |
| 18 Jun 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4,000 | — | |
| 18 Jun 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4,000 | 0.00 USD | deriv |
| 13 May 2025 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 37,622 | 0.00 USD | |
| 26 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 7,071 | 479.61 USD | |
| 24 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 4,716 | 483.28 USD | |
| 14 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 2,724 | 463.46 USD | |
| 12 Feb 2025 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 7,903 | 0.00 USD | |
| 10 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 3,220 | 467.98 USD | |
| 04 Feb 2025 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 8,448 | 0.00 USD | |
| 04 Feb 2025 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 14,624 | 0.00 USD | |
| 21 Jun 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 3,000 | — | |
| 21 Jun 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 4,000 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 14,000 | 0.00 USD | deriv |
| 15 May 2024 | SALE | VERTEX PHARMACEUTICALS INC / MA | 69 | 430.93 USD | |
| 26 Feb 2024 | SALE | VERTEX PHARMACEUTICALS INC / MA | 5,034 | 425.70 USD |